Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Annals of Surgical Oncology|July 2, 2024
Interdisciplinary Implementation of a Synoptic Reporting Template for Melanoma Nodal Surveillance UltrasoundKelsey B Montgomery, Zoey N Duncan, Ashley M Holder, et al.
Human Molecular Genetics|January 11, 2007
Genome-wide oligonucleotide-based array comparative genome hybridization analysis of non-isolated congenital diaphragmatic herniaDaryl A Scott, Merel Klaassens, Ashley M Holder, et al.
The Journal of Surgical Research|August 30, 2025
Leadership in Action: Tales From the TrenchesBrittany M Dacier, Cary B Aarons, Karl Y Bilimoria, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 21, 2018
Chemotherapy Sensitizes Therapy-Resistant Cells to Mild Hyperthermia by Suppressing Heat Shock Protein 27 Expression in Triple-Negative Breast CancerChaofeng Mu, Xiaoyan Wu, Xinyu Zhou, et al.
Oncotarget|May 7, 2015
Epithelial to mesenchymal transition is associated with rapamycin resistanceAshley M Holder, Argun Akcakanat, Farrell Adkins, et al.
Breast Cancer Research and Treatment|December 5, 2012
High stearoyl-CoA desaturase 1 expression is associated with shorter survival in breast cancer patientsAshley M Holder, Ana M Gonzalez-Angulo, Huiqin Chen, et al.
American Journal of Medical Genetics. Part A|July 17, 2009
Chromosome 8p23.1 deletions as a cause of complex congenital heart defects and diaphragmatic herniaMargaret J Wat, Oleg A Shchelochkov, Ashley M Holder, et al.
Oncotarget|September 28, 2014
Catalytic mTOR inhibitors can overcome intrinsic and acquired resistance to allosteric mTOR inhibitorsBurhan Hassan, Argun Akcakanat, Takafumi Sangai, et al.
Human Molecular Genetics|June 23, 2012
Mouse model reveals the role of SOX7 in the development of congenital diaphragmatic hernia associated with recurrent deletions of 8p23.1Margaret J Wat, Tyler F Beck, Andrés Hernández-García, et al.
Cancer|March 15, 2026
High dietary fiber is associated with improved outcomes in patients with melanoma and sarcoma treated with immunotherapy regardless of gut microbiome dysbiosis and social vulnerabilityBrittany C Fields, Raymond S Traweek, Kai Jiang, et al.
Pageof 3